(Q38871240)

7 September 2017

title

Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor (English)

1 reference

7 September 2017

1 reference

1

G Justus Hofmeyr

1 reference

7 September 2017

2

Bukola Fawole

1 reference

7 September 2017

Kidza Mugerwa

3

1 reference

7 September 2017

N Patrick Godi

4

1 reference

7 September 2017

Quentin Blignaut

5

1 reference

7 September 2017

Lindeka Mangesi

6

1 reference

7 September 2017

Mandisa Singata

7

1 reference

7 September 2017

Leanne Brady

8

1 reference

7 September 2017

Jennifer Blum

9

1 reference

7 September 2017

publication date

4 December 2010

1 reference

International Journal of Gynecology and Obstetrics

7 September 2017

published in

1 reference

7 September 2017

volume

112

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

98-102

1 reference

Primary postpartum haemorrhage

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

Levels and causes of maternal mortality in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

WHO multicentre randomised trial of misoprostol in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

Misoprostol to treat postpartum haemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

Preventing postpartum hemorrhage in low-resource settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

High fever following postpartum administration of sublingual misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.08.019

10.1016/J.IJGO.2010.08.019

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference